Funding & Investment2026-03-18
Mave Health Raises $2.1M Seed to Launch tDCS Brain-Training Wearable
Mave Health announced $2.1 million in seed funding led by Blume Ventures with participation from Stanford Angels, Dhaval Shroff, and Raymond Russell. The company develops a 100-gram wearable headset that uses transcranial direct current stimulation (tDCS) to train the prefrontal cortex for improved focus, stress regulation, and decision-making. Each session lasts 20 minutes at 1-2 mA intensity. The Mave headset is available for pre-order at $495 with no subscription fees, and shipping began in April 2026 to customers in the US and India.
Funding & Investment2026-03-18
Mave Health Raises $2.1M and Launches tDCS Focus and Stress Wearable Headset
Mave Health (San Francisco / Bengaluru, founded 2023) announced a $2.1M seed round led by Blume Ventures with participation from Stanford Angels and Tesla Autopilot AI lead Dhaval Shroff, and simultaneously launched its consumer tDCS headset. The $495 device delivers low-intensity electrical stimulation to the prefrontal cortex during 20-minute daily sessions targeting focus, mood, and stress regulation. The device is 100 grams, lasts one month per charge, and targets first shipments to US and India in April 2026 following 500+ beta customers. The 20-minute daily use case maps directly onto meditation session durations and positions tDCS as a contemplative practice augmentation tool.
